Patients News | pharmaphorum

News

Blood sample with respiratory coronavirus positive

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi

News

Boots, Macmillan offer free video consultations to cancer pa...

People living with cancer will be able to access free video consultations in their own homes under a new scheme launched by pharmacy chain Boots and the charity Macmillan Cance

News

Indivior ex-CEO could face jail time after opioid conviction

The resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – and possible prison sentence – after he pleaded guilty in a US feder

News

As CHMP backs Vertex’ CF triple, campaigners plead for speed...

Cystic fibrosis patient groups in the UK are celebrating a recommendation by the EMA’s human medicines committee to approve Vertex' three-drug therapy Kaftrio – but fear anothe

News

US advisors add steroids to COVID-19 drug recommendations

The Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with COVID-19.

News

NICE says no to Novartis’ Mayzent in secondary progressive M...

There isn’t enough evidence to back the use of Novartis Mayzent for secondary progressive multiple sclerosis on the NHS (SPMS), despite a desperate lack of treatments for this

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Boots, Macmillan offer free video consultations to cancer pa...

Indivior ex-CEO could face jail time after opioid conviction

As CHMP backs Vertex’ CF triple, campaigners plead for speed...

US advisors add steroids to COVID-19 drug recommendations

NICE says no to Novartis’ Mayzent in secondary progressive M...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks